European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.56% to 1,476.60 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and medical device maker EDAP TMS (EDAP), which rose 5.1% and 3.3%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and internet browser company Opera (OPRA), which were up 2.3%, each.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which fell 2% and 1.7%, respectively. They were followed by telecommunications company VEON (VEON) and electronics company Philips (PHG), which were down 0.9% each.
From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and NuCana (NCNA), which advanced 20% and 7.2%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and software firm Endava (DAVA), which increased 4.1% and 3%.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Akari Therapeutics (AKTX), which lost 6.5% and 1.9%, respectively. They were followed by utilities company National Grid (NGG) and insurance company Prudential (PUK), which dropped 1.3% each.
Comments